ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?

Abbott Laboratories ABT recently received Health Canada approval for the i-STAT TBI test cartridge for use with whole blood. It is designed to help clinicians assess suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes. The latest approval expands the company’s TBI test offerings, which include the i-STAT TBI Plasma test, and the ARCHITECT and Alinity i lab test (serum and plasma). ABT Stock’s Likely Trend...